Fibrogen Inc

Ownership Transactions Reported by 20 Insiders

Symbol
FGEN on Nasdaq
Location
350 Bay Street, Suite 100 #6009, San Francisco, CA

Insiders trading volume in the past year

Fibrogen Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Rory B. Riggs Director $761K May 26, 2021
Enrique A. Conterno Chief Executive Officer, Director $306K Jul 7, 2023
Thane Wettig CEO, Director $227K +$84.4K +59% Nov 13, 2025
Pat Cotroneo Executive Advisor & Former CFO $209K Sep 7, 2021
Thomas F. Kearns Jr Director $190K Sep 15, 2021
Mark Eisner EVP, Chief Medical Officer $122K Sep 6, 2023
Christine Chung Svp, China Operations $115K Mar 6, 2025
Deyaa Adib Chief Medical Officer $96.1K Jun 12, 2024
Juan Graham Chief Financial Officer $56.4K Dec 6, 2024
David DeLucia Chief Financial Officer $54.9K Jun 6, 2025
Gerald Lema Director $34.5K Jun 5, 2024
Kalevi Kurkijarvi Director $28.7K May 26, 2021
Suzanne Blaug Director $22.5K Jun 5, 2024
Jeffrey William Henderson Director $21.9K Sep 1, 2023
Benjamin Cravatt Director $21.8K Jun 5, 2024
Aoife Brennan Director $21.2K Jun 5, 2024
James A. Schoeneck Director $11.9K +$105K Jun 30, 2025
Michael Kauffman Director Jun 4, 2025
Jeffrey L. Edwards Director Jun 4, 2025
Maykin Ho Director Jun 4, 2025

Recent Insider Transactions by Companies or Individuals for Fibrogen Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.